ODTX (Odyssey Therapeutics) Total Assets: $229.07 Mil (As of Mar. 2026)


ODTX Odyssey Therapeutics Inc ODTX
9 GF Score
Price $19.23
! 2 Warning Signs
View Full Analysis

What is Odyssey Therapeutics Total Assets?

Odyssey Therapeutics ODTX +1.91% 9 Total Assets is $229.07 Mil as of Mar. 2026. GuruFocus rates ODTX with a GF Score™ of 9/100. The stock has 2 warning signs investors should review.

Odyssey Therapeutics's Total Assets for the quarter that ended in Mar. 2026 was $229.07 Mil.

During the past 12 months, Odyssey Therapeutics's average Total Assets Growth Rate was 29.90% per year. During the past 3 years, the average Total Assets Growth Rate was 5.10% per year.

During the past 4 years, Odyssey Therapeutics's highest 3-Year average Total Assets Growth Rate was 5.10%. The lowest was 5.10%. And the median was 5.10%.

Total Assets is connected with ROA %. Odyssey Therapeutics's annualized ROA % for the quarter that ended in Mar. 2026 was -61.36%. Total Assets is also linked to Revenue through Asset Turnover. Odyssey Therapeutics's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Odyssey Therapeutics  (NAS:ODTX) Total Assets Explanation

Total Assets is connected with ROA %.

Odyssey Therapeutics's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-153.048/( (269.788+229.07)/ 2 )
=-153.048/249.429
=-61.36 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Odyssey Therapeutics's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (269.788+229.07)/ 2 )
=0/249.429
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Odyssey Therapeutics Total Assets Related Terms

Odyssey Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Odyssey Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Odyssey Therapeutics Total Assets Chart

Odyssey Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Assets
317.15 286.52 197.44 269.79

Odyssey Therapeutics Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial 221.54 197.44 0.00 269.79 229.07
ODTX
9GF Score
Odyssey Therapeutics Inc ODTX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Odyssey Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Odyssey Therapeutics's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=-488.278+758.066
=269.79

Odyssey Therapeutics's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=-523.694+752.764
=229.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $229.07 Mil mean?
Odyssey Therapeutics (ODTX) has a Total Assets of $229.07 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Odyssey Therapeutics and its competitors.
Is Odyssey Therapeutics' Total Assets too high?
Odyssey Therapeutics' current Total Assets is $229.07 Mil. Overall, Odyssey Therapeutics has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Odyssey Therapeutics' Total Assets compare to VOR and PHAT?
Odyssey Therapeutics' Total Assets of $229.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Odyssey Therapeutics and its competitors. Odyssey Therapeutics's current Total Assets is $229.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Therapeutics stock overvalued right now?
Odyssey Therapeutics (ODTX) has a current Total Assets of $229.07 Mil. The current Total Assets is $229.07 Mil. Odyssey Therapeutics' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Odyssey Therapeutics (ODTX), the current Total Assets is $229.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Odyssey Therapeutics Business Description

Address 51 Sleeper Street, Boston, MA, USA, 02210
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
9GF Score

Get the complete analysis for ODTX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.23
Price